Evidence map›Paper›PMID 39719527›Full record

ArticleNPJ digital medicine2024

Ecologically sustainable benchmarking of AI models for histopathology.

Yu-Chia Lan, Martin Strauch, Pourya Pilva, Nikolas E J Schmitz, Alireza Vafaei Sadr, Leon Niggemeier, Huong Quynh Nguyen, David L Hölscher, Tri Q Nguyen, Jesper Kers and 2 more

Abstract read
In one paragraph

Article in NPJ digital medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yu-Chia LanInstitute of Pathology, University Clinic Aachen, RWTH Aachen University, Aachen, Germany.ORCID http://orcid.org/0000-0002-8327-4642
Martin StrauchInstitute of Pathology, University Clinic Aachen, RWTH Aachen University, Aachen, Germany.
Pourya PilvaInstitute of Pathology, University Clinic Aachen, RWTH Aachen University, Aachen, Germany.
Nikolas E J SchmitzInstitute of Pathology, University Clinic Aachen, RWTH Aachen University, Aachen, Germany.
Alireza Vafaei SadrInstitute of Pathology, University Clinic Aachen, RWTH Aachen University, Aachen, Germany.
Leon NiggemeierInstitute of Pathology, University Clinic Aachen, RWTH Aachen University, Aachen, Germany.
Huong Quynh NguyenInstitute of Pathology, University Clinic Aachen, RWTH Aachen University, Aachen, Germany.
David L HölscherInstitute of Pathology, University Clinic Aachen, RWTH Aachen University, Aachen, Germany.
Tri Q NguyenDepartment of Pathology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Jesper KersDepartment of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Roman D Bülow *Institute of Pathology, University Clinic Aachen, RWTH Aachen University, Aachen, Germany.ORCID http://orcid.org/0000-0002-8527-7353
Peter Boor *Institute of Pathology, University Clinic Aachen, RWTH Aachen University, Aachen, Germany. pboor@ukaachen.de.ORCID http://orcid.org/0000-0001-9921-4284

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) 322900939Deutsche Forschungsgemeinschaft (German Research Foundation) 445703531Deutsche Forschungsgemeinschaft (German Research Foundation) 454024652EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 101001791Nierstichting (Dutch Kidney Foundation) 17OKG23
6 · The paper itself

Abstract

Deep learning (DL) holds great promise to improve medical diagnostics, including pathology. Current DL research mainly focuses on performance. DL implementation potentially leads to environmental consequences but approaches for assessment of both performance and carbon footprint are missing. Here, we explored an approach for developing DL for pathology, which considers both diagnostic performance and carbon footprint, calculated as CO

Identifiers

PMID39719527
PMCPMC11668825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.